Suppression of carcinoma using high purity conjugated linoleic acid (CLA)
OwnerMichael C. Seidelinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerMichael C. Seidelinventor
Estimating the term…
A method for the treatment of carcinoma in a human is disclosed, including administering to a human a therapeutically effective amount of 9-cis, 11-trans octadecadienoic acid formed by reacting an ester of ricinoleic acid with a tosyl chloride or a mesyl chloride to form a tosylate or mesylate of an ester of ricinoleic acid, and reacting the tosylate or mesylate of an ester of ricinoleic acid with diazabicyclo-undecene. The method includes administering to a human a purified conjugated linoleic acid (CLA) produced by a novel synthesis process for producing 9-cis, 11-trans octadecadienoic acid at room temperature in high yield including providing a tosylate or mesylate of a methyl ester of ricinoleic acid and providing a purified 9-cis, 11-trans octadecadienoic acid formed when the tosylate or mesylate reacts with diazabicyclo-undecene.
A method for the treatment of carcinoma in a human, comprising:
A method for ameliorating the effects of carcinoma in a human, comprising:
A method for the treatment of carcinoma in a human, comprising:
Dependencies are inferred from the claim text.